Chemical inhibitors of TMEM106C include a variety of compounds that disrupt specific cellular processes and pathways to inhibit the protein's function. Phloretin, a dihydrochalcone found in apple tree leaves, can inhibit TMEM106C by interfering with its interactions with lipid bilayers, which are crucial for the protein's localization and function within the cell. On the other hand, Genistein, an isoflavone found in soy products, targets tyrosine kinases for inhibition, which can lead to reduced phosphorylation and subsequent inactivation of TMEM106C. Dynasore, a small molecule that inhibits the GTPase activity of dynamin, can prevent vesicular trafficking and endocytosis, essential processes for the correct localization and function of TMEM106C. Brefeldin A, a lactone antibiotic, disrupts the structure and function of the Golgi apparatus, potentially impeding the proper trafficking and processing of TMEM106C.
Furthermore, several kinase inhibitors have been identified that can alter the phosphorylation state of TMEM106C, thereby inhibiting its activity. PD 98059, an inhibitor of MEK, can reduce the activation of the MAPK/ERK pathway, which may be crucial for the phosphorylation and activation of TMEM106C. LY294002, a potent inhibitor of PI3K, and Wortmannin, another PI3K inhibitor, both can decrease the phosphorylation and subsequent activation of TMEM106C if it is involved in PI3K-mediated signaling pathways. SB203580, which selectively inhibits p38 MAPK, and Gö 6983, an inhibitor of protein kinase C, can decrease the phosphorylation of TMEM106C, resulting in reduced activity. Tunicamycin, an antibiotic that blocks N-linked glycosylation, can inhibit the maturation and function of glycoproteins, including TMEM106C, by preventing their proper folding and stability. Thapsigargin, an inhibitor of the sarco/endoplasmic reticulum Ca2+ ATPase, disrupts calcium homeostasis, which can inhibit TMEM106C if its function is dependent on calcium signaling. Lastly, Monensin, an ionophore that alters intracellular pH, can inhibit the trafficking and function of TMEM106C by disrupting protein transport within cellular organelles. Each of these chemicals targets specific cellular pathways and processes that are crucial for the functional activity of TMEM106C, leading to its inhibition.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Phloretin | 60-82-2 | sc-3548 sc-3548A | 200 mg 1 g | $63.00 $250.00 | 13 | |
Phloretin can inhibit TMEM106C by disrupting the protein's interaction with lipid bilayers, as it is known to disturb various cellular membrane-related processes. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $26.00 $92.00 $120.00 $310.00 $500.00 $908.00 $1821.00 | 46 | |
Genistein inhibits tyrosine kinases which could be critical for the phosphorylation state of TMEM106C, thus inhibiting its function. | ||||||
Dynamin Inhibitor I, Dynasore | 304448-55-3 | sc-202592 | 10 mg | $87.00 | 44 | |
Dynasore inhibits dynamin which can prevent vesicular trafficking and endocytosis, processes TMEM106C may rely on for its localization and function. | ||||||
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $30.00 $52.00 $122.00 $367.00 | 25 | |
Brefeldin A disrupts Golgi apparatus structure and function, which can inhibit TMEM106C's proper trafficking and processing. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $39.00 $90.00 | 212 | |
PD 98059 inhibits MEK, which is part of the MAPK/ERK pathway; inhibition of this pathway can reduce TMEM106C's phosphorylation and activation. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
LY294002 inhibits PI3K, potentially reducing the phosphorylation and activity of TMEM106C if it is involved in PI3K-related signaling. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $88.00 $342.00 | 284 | |
SB203580 selectively inhibits p38 MAPK, potentially decreasing TMEM106C's activity if it is regulated by p38 MAPK-dependent phosphorylation. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $66.00 $219.00 $417.00 | 97 | |
Wortmannin is a PI3K inhibitor, which could decrease the activation of TMEM106C if it is downstream of PI3K signaling. | ||||||
Gö 6983 | 133053-19-7 | sc-203432 sc-203432A sc-203432B | 1 mg 5 mg 10 mg | $103.00 $293.00 $465.00 | 15 | |
Gö 6983 inhibits protein kinase C, potentially reducing the phosphorylation and subsequent activity of TMEM106C. | ||||||
Tunicamycin | 11089-65-9 | sc-3506A sc-3506 | 5 mg 10 mg | $169.00 $299.00 | 66 | |
Tunicamycin prevents N-linked glycosylation, potentially inhibiting the maturation and function of glycoproteins like TMEM106C. | ||||||